On July 30, Yum rose 6.42% in regular trading, trading at approximately $160.71/share, with turnover of $35.93 million. The rally was driven by better-than-expected Q2 earnings and signs that the cyclospora outbreak headwind is subsiding.

Yum reported Q2 adjusted EPS of $1.62, beating the analyst consensus of $1.58 by 2.53% and representing a 12.5% year-over-year increase from $1.44. Revenue came in at $2.17 billion, up from $1.93 billion a year earlier, though slightly below the $2.18 billion estimate.

The stock had previously declined approximately 11% over seven consecutive trading days after the FDA linked a cyclospora outbreak to shredded iceberg lettuce served at Taco Bell locations in five states, with 1,644 reported infections. Taco Bell traffic at one point plunged over 30% year-over-year. However, the FDA has since confirmed the positive test on Taylor Farms lettuce was a false positive, and Taco Bell has completed full removal and replacement of affected ingredients. CEO Chris Turner acknowledged the outbreak caused significant short-term sales impact but emphasized consumers increasingly recognize it as an industry-wide issue rather than a brand-specific risk.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)